SAREPTA THERAPEUTICS, INC. Assets Held-for-sale, Not Part of Disposal Group, Current
SAREPTA THERAPEUTICS, INC. (SRPT) had Assets Held-for-sale, Not Part of Disposal Group, Current of $1.50 million as of 2017-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent · last filed 2019-02-28
- 2017-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $1.50M.
- 2017-09-30: Assets Held-for-sale, Not Part of Disposal Group, Current $1.50M.
- 2017-06-30: Assets Held-for-sale, Not Part of Disposal Group, Current $1.53M.
- 2017-03-31: Assets Held-for-sale, Not Part of Disposal Group, Current $1.50M; Assets Held-for-sale, Not Part of Disposal Group, Current as first filed $1.53M.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current | Assets Held-for-sale, Not Part of Disposal Group, Current as first filed |
|---|---|---|
| 2017-12-31 | $1.50M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $1.50M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $1.53M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.50M 10-Q · filed 2017-11-01 | $1.53M 10-Q · filed 2017-05-04 |
| 2016-07-31 | $1.50M 10-Q · filed 2018-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |